Sanofi (SNY) stock price, news, quote and history

Sanofi (SNY) Stock Price, News, Quote & History

These French Companies Have Global Reach. The Stocks Are Bargains.

Sanofi & Teva’s IBD drug prompts long-term clinical remission in Phase IIb trial

Sanofi and ScionxBio partner on mRNA therapies

Teva Pharmaceuticals, Sanofi Report Positive 44-Week Duvakitug Data in Ulcerative Colitis, Crohn's Disease

ScionxBio Announces Collaboration to Develop Long-Acting xRNA Therapeutics

UEG Week: Teva and Sanofi’s Duvakitug Maintained Long-Term Positive Outcomes in New Phase 2b Data for Ulcerative Colitis and Crohn’s Disease

Enable Injections Announces Approval in Japan for CirCLIQ® Injector based on enFuse® On-Body Delivery System

Press Release: Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany

Which Pharma Stock Looks More Attractive: Sanofi or AbbVie?

GSK vs. SNY: Which Europe-Based Pharma Stock Has More Potential?

Antipodes Exited Sanofi (SNY) After Repeated Pipeline Setbacks

R&D Change Underlines Sanofi SA (SNY) Prospects as One of the Best Dividend Stocks to Buy

Deutsche Bank Cuts PT on Sanofi (SNY) – Here’s Why